Bloomberg Markets: Abercrombie & Fitch Plunges, Coke Endowments

Bloomberg Markets: Abercrombie & Fitch Plunge...

Up next

Bloomberg Businessweek Weekend - March 20th, 2026

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily." Hosted by Carol Massar and Tim StenovecHear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius ...  Show more

Trump Fans Iran Quagmire Fears With Debate on Seizing Kharg

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. US officials say the White House is sending hundreds of Marines to the Middle East as it weighs a plan to seize Iran’s Kharg Island oil export hub. D ...  Show more

Recommended Episodes

Michael Bloomberg's Dark And Terrible Life Story
Worst Year Ever

Robert, Katy, and Cody discuss former New York Mayor and presidential candidate, Michael Bloomberg. Best Bloomberg Ever! Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information. 

BONUS EPISODE: Bloomberg Surveillance in Jackson Hole
Odd Lots

Bloomberg Surveillance comes to the Odd Lots podcast!  Listen for a special edition of Bloomberg Surveillance from the Federal Reserve's annual symposium in Jackson Hole, Wyoming.  Hear more from Bloomberg Surveillance on Apple or Spotify. Guests in this episode: Mohamed El-Erian ...  Show more

Bloomberg Wall Street Week: May 27th, 2022
Wall Street Week

One of the most iconic brands in financial television returns for today's issues and today's world. On this edition of Wall Street Week, Liz Ann Sonders, Charles Schwab Chief Investment Strategist & Ben Inker, GMO Co-Head of Asset Allocation wrap up a volatile week in the markets ...  Show more

Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg Surveillance

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more